Revenue generating & rising, along with another US$2M expected from NIH.
Two expected CE approvals in Q3:
"Imricor understands that given the advanced stage of the approval processes that Imricor has reached, it would be extremely
unlikely for CE mark approval not to be granted, and Imricor expects that it will receive CE mark approval for the Vision-MR
Ablation Catheter and the Vision-MR Dispersive Electrode in Q3 2019"
Ann: Top 20 Holders, page-4
Add IMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.0¢ |
Change
-0.040(4.71%) |
Mkt cap ! $218.8M | |||
| Open | High | Low | Value | Volume |
| 85.0¢ | 86.5¢ | 81.0¢ | $214.2K | 252.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1999 | 81.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 83.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMR (ASX) Chart |